Malignant Neoplasms

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA approval · 2026-02-19
EMA Authorised: Fulphila (pegfilgrastim) — Biosimilar Collaborations Ireland Limited
EMA authorised Fulphila, a pegfilgrastim biosimilar by Biosimilar Collaborations Ireland Limited. The approval covers its use to reduce the …